Gene · 5861
RAB1A: RAB1A, member RAS oncogene family
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. RAB1A: RAB1A, member RAS oncogene family. Genes, record 5861. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/5861
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P62820 | Ras-related protein Rab-1A | 205 | 15 | Ensembl, GeneID, HGNC |
Source UniProt
Patents35
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4801540 A1 | 2026-09-09 | 7 | P62820 | Espacenet |
| JP 2026506308 A | 2026-02-24 | 3 | P62820 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 60660 | P62820 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 12154 | P62820 | Espacenet |
| EP 4642905 A1 | 2025-11-05 | 3 | P62820 | Espacenet |
| EP 4615967 A1 | 2025-09-17 | 3 | P62820 | Espacenet |
| KR 1020250121452 A | 2025-08-12 | 3 | P62820 | Espacenet |
| EP 4587563 A1 | 2025-07-23 | 3 | P62820 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 12154 | P62820 | Espacenet |
| KR 1020250084989 A | 2025-06-11 | 3 | P62820 | Espacenet |
1 to 10 of 35
See all 35 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,347
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | RAB1A papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 17 | 2025 |
| R01GM083144 | Characterization of mammalian COG complex-interacting Golgi trafficking machinery | 11 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 9 | 2025 |
| ZIAHD008893 | Virulence strategies of the respiratory pathogen Legionella pneumophila | 7 | 2025 |
| R35GM136258 | GTPase Regulation of the Golgi Complex | 6 | 2025 |
| R01GM035370 | Genetics of secretion in yeast | 4 | 2025 |
| U19AI135990 | HPMI: Host Pathogen Mapping Initiative | 4 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 3 | 2025 |
| R01NS092823 | The role of a-synuclein accumulation in lysosomal hydrolase trafficking and function | 3 | 2025 |
| T32CA009302 | Leveraging innovative technologies in basic and clinical cancer research | 3 | 2025 |
1 to 10 of 1,347Source NIH's project files
See all 1,347 nih grantsPapers2,400
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative Cross-Population Multi-Database Analysis Reveals an Association Between GORASP2 and Autophagy in Glioblastoma. | J Pak Med Assoc | 2026 | 42817668 | PubTator, text mining | PubMed |
| Rab1A Promotes Hepatic Steatosis by Suppressing Mitophagy via the Raf-1/ERK1/2/PINK1 Signaling Axis. | Adv Sci (Weinh) | 2026 | 42801566 | PubTator, text mining | PubMed |
| RAB1 mediates OPTN-dependent mitophagy via ATG9A recruitment. | Autophagy | 2026 | 42681746 | PubTator, text mining | PubMed |
| Crotonylome profiling identifies MLKL crotonylation in lupus nephritis associated with RAB1A-mTOR signalling and autophagy changes in tubular epithelial cells. | Lupus Sci Med | 2026 | 42674810 | PubTator, text mining | PubMed |
| In sample pH measurement by 31P phosphate NMR: application to measure the intrinsic GTPase activity of Rab1a. | Eur Biophys J | 2026 | 42347928 | PubTator, text mining | PubMed |
| Rab1A-Mediated Exosomal Sorting of miR-200c Enhances Breast Cancer Lung Metastasis [Retraction]. | Breast Cancer (Dove Med Press) | 2026 | 42318227 | PubTator, text mining | PubMed |
| Tumor regression pattern and distribution of residual tumor cells in potential candidates for local excision of rectal cancer: a prospective cohort study. | Tech Coloproctol | 2026 | 42307785 | PubTator, text mining | PubMed |
| ER-Golgi dysfunction and vesicular transport alterations in rheumatoid arthritis immune cells. | Front Immunol | 2026 | 42220485 | PubTator, text mining | PubMed |
| A novel RAB5 binding site in human VPS34-CII that is likely the primordial site in eukaryotic evolution. | Elife | 2026 | 42207670 | PubTator, text mining | PubMed |
| Renal cell carcinoma with a novel RAB1A::ALK fusion: expanding the molecular spectrum of ALK-rearranged RCC. | Virchows Arch | 2026 | 42096086 | PubTator, text mining | PubMed |
1 to 10 of 2,400
See all 2,400 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/5861
GET https://conductscience.org/api/genes/v1/5861/patents?page=2